Contract №2814046 Pharmaceutical products. Winner: STORKPHARM Sp. z o.o.

Link to original

To view links to the source need to register

Publication date

22-09-2017

Description

Section I
1. Name and addresses
  Katowickie Centrum Onkologii
  ul. Raciborska 26
  Katowice
  40-074
  Poland
  Telephone: +48 324200210
  E-mail: [email protected]
  Fax: +48 322514533
2. Type of the contracting authority:
  Body governed by public law
3. Main activity:
  Health
Section II
1. Scope of the procurement:
  1. Title:
    
    Zakup i dostarczanie leków 300 Pakietów.
    
    Reference number: KCO/PN/5/2017
  2. Main CPV code:
    33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110, 33141110
  3. Type of contract:
    Supplies
  4. Short description:
    
    Przedmiotem zamówienia jest zakup i dostarczanie produktów leczniczych – leków, środków kontrastowych, płynów infuzyjnych i materiałów opatrunkowych dla potrzeb Katowickiego Centrum Onkologii w postaciach, dawkach i szacunkowych ilościach, których wykaz w podziale na Pakiety od Nr 1 do Nr 300 stanowi Załącznik Nr 2 do SIWZ – Oferta Cenowa.
    
    Przedmiotem zamówienia jest produkt leczniczy – lek o nazwie międzynarodowej w określonej przez Zamawiającego postaci i dawce, natomiast umieszczona nazwa handlowa jest jedynie egzemplifikacją, podaną celem usystematyzowania katalogu.
  5. Information about lots:
    This contract is divided into lots: yes
  6. Total value of the procurement:
    Value excluding VAT: 37 417 792.28 PLN
2. Description
  1. Title:
    
    Pakiet 1
  2. Additional CPV code(s):
    33600000
  3. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  4. Description of the procurement:
    
    Acidum zoledronicum Zoledronic Acid inj. 4mg/5ml, 1 fiol. ILOŚĆ 1000.
  5. Award criteria:
  6. Information about options:
    Options: no
  7. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  8. Additional information:
  9. Title:
    
    Pakiet 2
  10. Additional CPV code(s):
    33600000
  11. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  12. Description of the procurement:
    
    Afatinib Giotrif 20 mg x 28 tabl. ILOŚĆ 130
    
    Afatinib Giotrif 30 mg x 28 tabl. ILOŚĆ 110
    
    Afatinib Giotrif 40 mg x 28 tabl. ILOŚĆ 30.
  13. Award criteria:
  14. Information about options:
    Options: no
  15. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  16. Additional information:
  17. Title:
    
    Pakiet 3
  18. Additional CPV code(s):
    33600000
  19. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  20. Description of the procurement:
    
    Axitynib Inlyta tabl. powl. 1 mg x 56 szt. ILOŚĆ 150
    
    Axitynib Inlyta tabl. powl. 5 mg x 56 szt. ILOŚĆ 50.
  21. Award criteria:
  22. Information about options:
    Options: no
  23. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  24. Additional information:
  25. Title:
    
    Pakiet 4
  26. Additional CPV code(s):
    33600000
  27. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  28. Description of the procurement:
    
    Aprepitanum Emend kaps. 125mg, 80mg x 3 szt. ILOŚĆ 450.
  29. Award criteria:
  30. Information about options:
    Options: no
  31. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  32. Additional information:
  33. Title:
    
    Pakiet 5
  34. Additional CPV code(s):
    33600000
  35. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  36. Description of the procurement:
    
    Bevacizumab Avastin, 0,1g/4ml, konc.rozt.infuz., 1 fiol. ILOŚĆ 900
    
    Bevacizumab Avastin, 0,4g/16ml, konc.rozt.infuz., 1 fiol. ILOŚĆ 900.
  37. Award criteria:
  38. Information about options:
    Options: no
  39. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  40. Additional information:
  41. Title:
    
    Pakiet 6
  42. Additional CPV code(s):
    33600000
  43. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  44. Description of the procurement:
    
    Bicalutamidum Bicalutamide 50 mg, tabl., 28 szt. ILOŚĆ 150.
  45. Award criteria:
  46. Information about options:
    Options: no
  47. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  48. Additional information:
  49. Title:
    
    Pakiet 7
  50. Additional CPV code(s):
    33600000
  51. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  52. Description of the procurement:
    
    Cisplatinum Cisplatin 0,01 g/10ml, rozt.do inj., 1 fiol. ILOŚĆ 500
    
    Cisplatinum Cisplatin 0,1 g/100ml, rozt.do inj., 1 fiol. ILOŚĆ 3500.
  53. Award criteria:
  54. Information about options:
    Options: no
  55. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  56. Additional information:
  57. Title:
    
    Pakiet 8
  58. Additional CPV code(s):
    33600000
  59. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  60. Description of the procurement:
    
    Dabrafenibum Tafinlar 50mg, kaps. 120szt ILOŚĆ 70
    
    Dabrafenibum Tafinlar 75mg, kaps. 120szt ILOŚĆ 70.
  61. Award criteria:
  62. Information about options:
    Options: no
  63. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  64. Additional information:
  65. Title:
    
    Pakiet 9
  66. Additional CPV code(s):
    33600000
  67. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  68. Description of the procurement:
    
    Darbepoetinum alfa Aranesp inj. 500mcg/1ml x 1 wstrz. ILOŚĆ 330.
  69. Award criteria:
  70. Information about options:
    Options: no
  71. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  72. Additional information:
  73. Title:
    
    Pakiet 10
  74. Additional CPV code(s):
    33600000
  75. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  76. Description of the procurement:
    
    Denosumab Xgeva, 120mg/1,7ml roztw. do inj. x 1 fiol. ILOŚĆ 180.
  77. Award criteria:
  78. Information about options:
    Options: no
  79. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  80. Additional information:
  81. Title:
    
    Pakiet 11
  82. Additional CPV code(s):
    33600000
  83. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  84. Description of the procurement:
    
    Doxorubicini liposomamum pegylatum Caelyx 20 mg/10ml, inj., 1 fiol.a 10ml ILOŚĆ 500.
  85. Award criteria:
  86. Information about options:
    Options: no
  87. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  88. Additional information:
  89. Title:
    
    Pakiet 12
  90. Additional CPV code(s):
    33600000
  91. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  92. Description of the procurement:
    
    Fulvestrant Faslodex, 250 mg/5 ml, rozt. do wstrzyk., 2 amp.-strz. ILOŚĆ 200.
  93. Award criteria:
  94. Information about options:
    Options: no
  95. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  96. Additional information:
  97. Title:
    
    Pakiet 13
  98. Additional CPV code(s):
    33600000
  99. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  100. Description of the procurement:
    
    Gefitynib Iressa tabl. 250 mg x 30 tabl. ILOŚĆ 80.
  101. Award criteria:
  102. Information about options:
    Options: no
  103. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  104. Additional information:
  105. Title:
    
    Pakiet 14
  106. Additional CPV code(s):
    33600000
  107. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  108. Description of the procurement:
    
    Hydroxycarbamidum Hydroxycarbamid Teva 0,5 g, kaps., 100 szt. ILOŚĆ 8.
  109. Award criteria:
  110. Information about options:
    Options: no
  111. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  112. Additional information:
  113. Title:
    
    Pakiet 15
  114. Additional CPV code(s):
    33600000
  115. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  116. Description of the procurement:
    
    Imatynib Glivec 100 mg x 120 tabl. powl.* ILOŚĆ 35
    
    Imatynib Glivec 400 mg x 90 tabl. powl.* ILOŚĆ 230
    
    * lek posiadający rejestrację w leczeniu nowotworów podścieliskowych przewodu pokarmowego.
  117. Award criteria:
  118. Information about options:
    Options: no
  119. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  120. Additional information:
  121. Title:
    
    Pakiet 16
  122. Additional CPV code(s):
    33600000
  123. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  124. Description of the procurement:
    
    Imatynib Imatinib Accord 100 mg x 60 tabl. powl. ILOŚĆ 12
    
    Imatynib Imatinib Accord 400 mg x 30 tabl. powl. ILOŚĆ 24.
  125. Award criteria:
  126. Information about options:
    Options: no
  127. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  128. Additional information:
  129. Title:
    
    Pakiet 17
  130. Additional CPV code(s):
    33600000
  131. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  132. Description of the procurement:
    
    ILomustinum Cecenu, 0,04 g, kaps., 20 kaps. ILOŚĆ 12.
  133. Award criteria:
  134. Information about options:
    Options: no
  135. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  136. Additional information:
  137. Title:
    
    Pakiet 18
  138. Additional CPV code(s):
    33600000
  139. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  140. Description of the procurement:
    
    Lipegfilgrastimum Lonquex inj. 6mg/0,6ml, 1 ampstrz. ILOŚĆ 1000.
  141. Award criteria:
  142. Information about options:
    Options: no
  143. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  144. Additional information:
  145. Title:
    
    Pakiet 19
  146. Additional CPV code(s):
    33600000
  147. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  148. Description of the procurement:
    
    Methotrexatum Methotrexat 10mg/1ml inj. 10 amp. ILOŚĆ 120
    
    Methotrexatum Methotrexat 50mg/5ml, inj., 5 amp. ILOŚĆ 150.
  149. Award criteria:
  150. Information about options:
    Options: no
  151. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  152. Additional information:
  153. Title:
    
    Pakiet 20
  154. Additional CPV code(s):
    33600000
  155. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  156. Description of the procurement:
    
    Methotrexatum Methotrexat 2,5mg, tabl., 50 szt. ILOŚĆ 30.
  157. Award criteria:
  158. Information about options:
    Options: no
  159. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  160. Additional information:
  161. Title:
    
    Pakiet 21
  162. Additional CPV code(s):
    33600000
  163. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  164. Description of the procurement:
    
    Mitoxantronum Mitoxantron 0,02g/10ml, inj., 1 fiol. ILOŚĆ 100.
  165. Award criteria:
  166. Information about options:
    Options: no
  167. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  168. Additional information:
  169. Title:
    
    Pakiet 22
  170. Additional CPV code(s):
    33600000
  171. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  172. Description of the procurement:
    
    Natrii pamidronas Pamisol, 0,09 g/10ml, subst.z rozpuszcz., 1 fiol.s.subs.+1rozp ILOŚĆ 80.
  173. Award criteria:
  174. Information about options:
    Options: no
  175. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  176. Additional information:
  177. Title:
    
    Pakiet 23
  178. Additional CPV code(s):
    33600000
  179. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  180. Description of the procurement:
    
    Netupitant/Palonosetron Akynzeo kaps. 300mg+0,5mg, 1 szt. ILOŚĆ 450.
  181. Award criteria:
  182. Information about options:
    Options: no
  183. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  184. Additional information:
  185. Title:
    
    Pakiet 24
  186. Additional CPV code(s):
    33600000
  187. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  188. Description of the procurement:
    
    Olaparibum Lynparza, kaps. 50 mg, 448 szt. ILOŚĆ 120.
  189. Award criteria:
  190. Information about options:
    Options: no
  191. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  192. Additional information:
  193. Title:
    
    Pakiet 25
  194. Additional CPV code(s):
    33600000
  195. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  196. Description of the procurement:
    
    Ondansetroni hydrochloridum Ondansetron, 8 mg/4ml, inj., 5 amp. ILOŚĆ 5000.
  197. Award criteria:
  198. Information about options:
    Options: no
  199. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  200. Additional information:
  201. Title:
    
    Pakiet 26
  202. Additional CPV code(s):
    33600000
  203. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  204. Description of the procurement:
    
    Oxaliplatinum Oxaliplatinum 100mg/20ml, konc.do inf., 1 fiol. ILOŚĆ 1800
    
    Oxaliplatinum Oxaliplatinum 50mg/10ml, konc.do inf., 1 fiol. ILOŚĆ 1800.
  205. Award criteria:
  206. Information about options:
    Options: no
  207. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  208. Additional information:
  209. Title:
    
    Pakiet 27
  210. Additional CPV code(s):
    33600000
  211. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  212. Description of the procurement:
    
    Pazopanib Votrient 400 mg, 60 tabl.powl. ILOŚĆ 220
    
    Pazopanib Votrient 200 mg, 30 tabl.powl. ILOŚĆ 100.
  213. Award criteria:
  214. Information about options:
    Options: no
  215. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  216. Additional information:
  217. Title:
    
    Pakiet 28
  218. Additional CPV code(s):
    33600000
  219. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  220. Description of the procurement:
    
    Pertuzumabum Perjeta konc.do sporz.r-ru do inf. 420 mg, 1 fiol. ILOŚĆ 350.
  221. Award criteria:
  222. Information about options:
    Options: no
  223. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  224. Additional information:
  225. Title:
    
    Pakiet 29
  226. Additional CPV code(s):
    33600000
  227. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  228. Description of the procurement:
    
    Rasburicasum Fasturtec inj. 1,5 mg/ml, 3 fiol.a 1,5 mg (+ 3 amp. rozp.) ILOŚĆ 60.
  229. Award criteria:
  230. Information about options:
    Options: no
  231. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  232. Additional information:
  233. Title:
    
    Pakiet 30
  234. Additional CPV code(s):
    33600000
  235. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  236. Description of the procurement:
    
    Trastuzumabum Herceptin r-r do wstrz. 600 mg, 1 fiol. ILOŚĆ 1200.
  237. Award criteria:
  238. Information about options:
    Options: no
  239. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  240. Additional information:
  241. Title:
    
    Pakiet 31
  242. Additional CPV code(s):
    33600000
  243. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  244. Description of the procurement:
    
    Wemurafenib Zelboraf 240 mg x 56 tabl. powl. ILOŚĆ 120.
  245. Award criteria:
  246. Information about options:
    Options: no
  247. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  248. Additional information:
  249. Title:
    
    Pakiet 32
  250. Additional CPV code(s):
    33600000
  251. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  252. Description of the procurement:
    
    Paramagnetyczny środek kontrastowy O stężeniu gadolinu 1,0 mmol/ml do badań MR niskiego ryzyka wystąpienia nerkopochodnego włóknienia układowego (NSF) a 7,5 ml x 1 amp.strz./amp. ILOŚĆ 300
    
    Paramagnetyczny środek kontrastowy O stężeniu gadolinu 1,0 mmol/ml do badań MR niskiego ryzyka wystąpienia nerkopochodnego włóknienia układowego (NSF) a 15 ml x 1 fiol. ILOŚĆ 1000.
  253. Award criteria:
  254. Information about options:
    Options: no
  255. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  256. Additional information:
  257. Title:
    
    Pakiet 33
  258. Additional CPV code(s):
    33600000
  259. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  260. Description of the procurement:
    
    Paramagnetyczny środek kontrastowy O stężeniu gadolinu 0,5 mmol/ml do badań MR niskiego ryzyka wystąpienia nerkopochodnego włóknienia układowego (NSF) a 15 ml x 1 fiol. ILOŚĆ 700
    
    Paramagnetyczny środek kontrastowy O stężeniu gadolinu 0,5 mmol/ml do badań MR niskiego ryzyka wystąpienia nerkopochodnego włóknienia układowego (NSF) a 20 ml x 1 fiol. ILOŚĆ 500.
  261. Award criteria:
  262. Information about options:
    Options: no
  263. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  264. Additional information:
  265. Title:
    
    Pakiet 34
  266. Additional CPV code(s):
    33600000
  267. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  268. Description of the procurement:
    
    Paramagnetyczny środek kontrastowy O stężeniu gadobenatu dimegluminy 0,5 mmol/ml dedykowany do badań MR wątroby, a 15 ml x 1 fiol. ILOŚĆ 50.
  269. Award criteria:
  270. Information about options:
    Options: no
  271. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  272. Additional information:
  273. Title:
    
    Pakiet 35
  274. Additional CPV code(s):
    33600000
  275. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  276. Description of the procurement:
    
    Niejonowy, niskoosmolarny środek kontrastowy O stężeniu od 370 do 400 mg jodu inj. 10 but a 100 ml ILOŚĆ 60
    
    Niejonowy, niskoosmolarny środek kontrastowy O stężeniu od 370 do 400 mg jodu inj. 10 but a 50 ml ILOŚĆ 20.
  277. Award criteria:
  278. Information about options:
    Options: no
  279. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  280. Additional information:
  281. Title:
    
    Pakiet 36
  282. Additional CPV code(s):
    33600000
  283. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  284. Description of the procurement:
    
    Niejonowy, niskoosmolarny środek kontrastowy Środek kontrastujący niejonowy 300 mg/1ml 1 but. a 500 ml inj. ILOŚĆ 2200
    
    Niejonowy, niskoosmolarny środek kontrastowy Środek kontrastujący niejonowy 300 mg/1ml 10 but. a 100 ml inj. ILOŚĆ 450
    
    Niejonowy, niskoosmolarny środek kontrastowy Środek kontrastujący niejonowy 300 mg/1ml 10 but. a 50 ml inj. ILOŚĆ 200.
  285. Award criteria:
  286. Information about options:
    Options: no
  287. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  288. Additional information:
  289. Title:
    
    Pakiet 37
  290. Additional CPV code(s):
    33600000
  291. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  292. Description of the procurement:
    
    Meglumini amidotrizoas Gastrografin rozt.do wl.doż., 10 fiol.a 100ml ILOŚĆ 250.
  293. Award criteria:
  294. Information about options:
    Options: no
  295. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  296. Additional information:
  297. Title:
    
    Pakiet 38
  298. Additional CPV code(s):
    33600000
  299. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  300. Description of the procurement:
    
    — Acidum boricum, 1 kg subst. ILOŚĆ 10
    
    — Acidum salicylicum, 1 kg subst. ILOŚĆ 2
    
    — Ammonium bit.-sulf.Ichtiol subst., 250g ILOŚĆ 8
    
    — Argentum nitricum, 10 g subst. ILOŚĆ 5
    
    — Benzocainum, 50 g subst. ILOŚĆ 30
    
    — Camphora, 50 g subst. ILOŚĆ 20
    
    — Carbo medicinalis, 50 g subst. ILOŚĆ 50
    
    — Cera flava, 50 g podłoże ILOŚĆ 170
    
    — Codeinum phosphoricum, 10 g subst. ILOŚĆ 80
    
    — Chloramfenikol, subst., 10 g ILOŚĆ 80
    
    — Dithranol, subst., 5 g ILOŚĆ 10
    
    — Euceryna Bezwodna, 1 kg ILOŚĆ 200
    
    — Formaldehyd solutio 37 %, płyn, 1 kg ILOŚĆ 5
    
    Formaldehyd solutio 10 %, płyn, 1 kg ILOŚĆ 800
    
    — Gentamycinum sulfuricum, 5 g subst. ILOŚĆ 5
    
    — Glukoza – 75 g prosz. ILOŚĆ 500
    
    — Glukoza – 50 g prosz. ILOŚĆ 250
    
    — Glicerolum 85 %, płyn, 1 kg ILOŚĆ 100
    
    — Gummi arabicum, 100 g subst. ILOŚĆ 15
    
    — Hydrocortisonum, 10 g subst. ILOŚĆ 250
    
    — Iodum, 5 g subst. ILOŚĆ 12
    
    — Jodyna, 800 g płyn ILOŚĆ 3
    
    — Kalium hypermanganicum, 5 g subst. ILOŚĆ 120
    
    — Kalium Iodatum, 50 g subst. ILOŚĆ 5
    
    — Lanolinum Anhydricum 1 kg ILOŚĆ 80
    
    Lekobaza 0,5 kg ILOŚĆ 50
    
    — Mentholum, 100 g subst. ILOŚĆ 4
    
    — Morphininum hydrochloricum, 5g subst. ILOŚĆ 4
    
    — Natrium chloratum, 1 kg subst. ILOŚĆ 8
    
    — Neomycinum, 10 g subst. ILOŚĆ 200
    
    Oleum ricini, 500 ml płyn ILOŚĆ 8
    
    — Oleum rapae, 800 ml płyn ILOŚĆ 50
    
    — Oleum cacao, 100 g subst. ILOŚĆ 15
    
    — Paraffinum liquidum, 800 g płyn ILOŚĆ 80
    
    — Pasta cynkowa,1 kg ILOŚĆ 40
    
    — Perhydrol 30 %, 1 kg płyn ILOŚĆ 5
    
    — Polocainum hydrochlor., 10 g subst. ILOŚĆ 8
    
    — Prednisolon, 5 g subst. ILOŚĆ 3
    
    Prodermina, 50 g subst. ILOŚĆ 5
    
    — Puder płynny 100 g ILOŚĆ 50
    
    — Pyralginum, 250 g subst. ILOŚĆ 15
    
    — Resorcinum, 50 g prosz. ILOŚĆ 3
    
    — Sapo kalinus, 100 g ILOŚĆ 40
    
    — Spiritus salicylowy, 800 g subst. ILOŚĆ 40
    
    — Sulfur praecipitatum, 500 g subst. ILOŚĆ 20
    
    — Talcum, 1 kg subst. ILOŚĆ 80
    
    — Urea pura (Rec.), subst., 100 g ILOŚĆ 8
    
    — Zincum oxydatum, 1 kg subst. ILOŚĆ 60
    
    — Vaselinum album, 1 kg ILOŚĆ 60
    
    — Vaselinum flavum, 1 kg ILOŚĆ 130
    
    — Woda utleniona 3 % 1000 g ILOŚĆ 180.
  301. Award criteria:
  302. Information about options:
    Options: no
  303. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  304. Additional information:
  305. Title:
    
    Pakiet 39
  306. Additional CPV code(s):
    33600000
  307. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  308. Description of the procurement:
    
    Aciclovirum Aciclovir 0,25 g, liof.do inj.doż., 5 fiol. ILOŚĆ 5
    
    Aciclovirum Hascovir, 0,4 g, tabl., 30 tabl. ILOŚĆ 130
    
    Aciclovirum Hascovir, 0,2 g, tabl., 30 tabl. ILOŚĆ 40.
  309. Award criteria:
  310. Information about options:
    Options: no
  311. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  312. Additional information:
  313. Title:
    
    Pakiet 40
  314. Additional CPV code(s):
    33600000
  315. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  316. Description of the procurement:
    
    Acidum acetylosalicylicum Polocard, 0,075 g, tabl., 60 szt. ILOŚĆ 300
    
    Acidum acetylosalicylicum Polocard, 0,15 g, tabl., 60 szt. ILOŚĆ 100
    
    Acidum acetylosalicylicum Polopiryna, 0,5 g, tabl.powl.dojel., 20 tabl. ILOŚĆ 50
    
    Acidum acetylosalicylicum Polopiryna S, 0,3 g, tabl.rozp., 20 tabl. ILOŚĆ 100.
  317. Award criteria:
  318. Information about options:
    Options: no
  319. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  320. Additional information:
  321. Title:
    
    Pakiet 41
  322. Additional CPV code(s):
    33600000
  323. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  324. Description of the procurement:
    
    Acidum ascorbicum Vit. C, 0,2 g, tabl.powl., 50 tabl. ILOŚĆ 100
    
    Acidum ascorbicum Vit. C 500mg/5ml, inj., 10 amp. ILOŚĆ 300.
  325. Award criteria:
  326. Information about options:
    Options: no
  327. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  328. Additional information:
  329. Title:
    
    Pakiet 42
  330. Additional CPV code(s):
    33600000
  331. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  332. Description of the procurement:
    
    Albendazole Zentel, 0,4 g, tabl., 1 tabl. ILOŚĆ 20
    
    Albendazole Zentel, 0,4 g/20ml zawiesina 20 ml ILOŚĆ 10.
  333. Award criteria:
  334. Information about options:
    Options: no
  335. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  336. Additional information:
  337. Title:
    
    Pakiet 43
  338. Additional CPV code(s):
    33600000
  339. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  340. Description of the procurement:
    
    Amlodipinum Aldan, 10 mg, tabl., 30 tabl. ILOŚĆ 160
    
    Amlodipinum Aldan, 5 mg, tabl., 30 tabl. ILOŚĆ 300.
  341. Award criteria:
  342. Information about options:
    Options: no
  343. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  344. Additional information:
  345. Title:
    
    Pakiet 44
  346. Additional CPV code(s):
    33600000
  347. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  348. Description of the procurement:
    
    Atropini sulfas Atropinum sulf., 0,5 mg/1ml, inj., 10 amp. ILOŚĆ 120
    
    Atropini sulfas Atropinum sulf., 1 mg/1ml, inj., 10 amp. ILOŚĆ 200
    
    Atropini sulfas Bellapan, 0,25 mg, tabl., 20 tabl. ILOŚĆ 20.
  349. Award criteria:
  350. Information about options:
    Options: no
  351. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  352. Additional information:
  353. Title:
    
    Pakiet 45
  354. Additional CPV code(s):
    33600000
  355. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  356. Description of the procurement:
    
    Benzylpenicillinum kalicum Penicill.cryst. 5 000 000 j.m., inj., 1 fiol.s.subs. ILOŚĆ 1000
    
    Benzylpenicillinum kalicum Penicill.cryst.,1 000 000 j.m., inj., 1 fiol.s.subs. ILOŚĆ 300.
  357. Award criteria:
  358. Information about options:
    Options: no
  359. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  360. Additional information:
  361. Title:
    
    Pakiet 46
  362. Additional CPV code(s):
    33600000
  363. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  364. Description of the procurement:
    
    Benzylpenicillinum procainum Penicill.proc., 1 200 000 j.m., inj., 1 fiol. ILOŚĆ 300
    
    Benzylpenicillinum procainum Penicill.proc., 2 400 000 j.m., inj., 1 fiol. ILOŚĆ 1500.
  365. Award criteria:
  366. Information about options:
    Options: no
  367. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  368. Additional information:
  369. Title:
    
    Pakiet 47
  370. Additional CPV code(s):
    33600000
  371. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  372. Description of the procurement:
    
    Bromhexini hydrochloridum Flegamina, 0,08 g/100ml, syrop, 120 ml ILOŚĆ 130
    
    Bromhexini hydrochloridum Flegamina, 8 mg, tabl., 40 szt. ILOŚĆ 200.
  373. Award criteria:
  374. Information about options:
    Options: no
  375. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  376. Additional information:
  377. Title:
    
    Pakiet 48
  378. Additional CPV code(s):
    33600000
  379. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  380. Description of the procurement:
    
    Budezonidum, Formoteroli Symbicort Turbuhaler proszek do inh. (160 mcg + 4,5 mcg) x 60 dawek ILOŚĆ 60
    
    Budezonidum, Formoteroli Symbicort Turbuhaler proszek do inh. (320 mcg + 9 mcg) x 60 dawek ILOŚĆ 60.
  381. Award criteria:
  382. Information about options:
    Options: no
  383. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  384. Additional information:
  385. Title:
    
    Pakiet 49
  386. Additional CPV code(s):
    33600000
  387. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  388. Description of the procurement:
    
    Carvedilolum Atram 6,25 mg, tabl., 30 szt. ILOŚĆ 180
    
    Carvediolum Atram 25 mg, tabl., 30 szt. ILOŚĆ 50.
  389. Award criteria:
  390. Information about options:
    Options: no
  391. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  392. Additional information:
  393. Title:
    
    Pakiet 50
  394. Additional CPV code(s):
    33600000
  395. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  396. Description of the procurement:
    
    Chlorpromazini hydrochloridum Fenactil 4 %, 0,04 g/1g, krople, 10 g ILOŚĆ 60
    
    Chlorpromazini hydrochloridum Fenactil, 0,025 g/5ml, inj.dom., 5 amp. ILOŚĆ 5
    
    Chlorpromazini hydrochloridum Fenactil, 0,05 g/2ml, inj.doż., 10 amp. ILOŚĆ 5.
  397. Award criteria:
  398. Information about options:
    Options: no
  399. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  400. Additional information:
  401. Title:
    
    Pakiet 51
  402. Additional CPV code(s):
    33600000
  403. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  404. Description of the procurement:
    
    Cisatarcurium Nimbex, 2 mg/1ml, rozt.do wl.doż., 5 amp.a 2,5ml ILOŚĆ 180
    
    Cisatarcurium Nimbex, 2 mg/1ml, rozt.do wl.doż., 5 amp.a 5ml ILOŚĆ 250.
  405. Award criteria:
  406. Information about options:
    Options: no
  407. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  408. Additional information:
  409. Title:
    
    Pakiet 52
  410. Additional CPV code(s):
    33600000
  411. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  412. Description of the procurement:
    
    Diazepamum Relanium 2 mg, tabl., 20 szt. ILOŚĆ 60
    
    Diazepamum Neorelium 5 mg, tabl., 20 szt. ILOŚĆ 200
    
    Diazepamum Relanium, 0,01 g/2ml, inj., 50 amp. ILOŚĆ 100.
  413. Award criteria:
  414. Information about options:
    Options: no
  415. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  416. Additional information:
  417. Title:
    
    Pakiet 53
  418. Additional CPV code(s):
    33600000
  419. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  420. Description of the procurement:
    
    Diclofenacum sodium Majamil PPH 0,05 g, tabl.powl.dojel., 30 tabl. ILOŚĆ 120
    
    Diclofenacum sodium Majamil prolong., 0,1 g, kaps., 20 tabl. ILOŚĆ 250
    
    Diclofenacum sodium Diclofenac 100, 0,1 g, czop., 10 czop. ILOŚĆ 150
    
    Diclofenacum sodium Naklofen 0,075 g/3ml, inj., 5 amp. ILOŚĆ 100
    
    Diclofenacum sodium Dikloziaja 1 %, żel, 50 g ILOŚĆ 350.
  421. Award criteria:
  422. Information about options:
    Options: no
  423. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  424. Additional information:
  425. Title:
    
    Pakiet 54
  426. Additional CPV code(s):
    33600000
  427. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  428. Description of the procurement:
    
    Doxepin hydrochloride Doxepin, 0,025 g, kaps., 30 kaps. ILOŚĆ 60
    
    Doxepin hydrochloride Doxepin, 0,01 g, kaps., 30 kaps. ILOŚĆ 80.
  429. Award criteria:
  430. Information about options:
    Options: no
  431. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  432. Additional information:
  433. Title:
    
    Pakiet 55
  434. Additional CPV code(s):
    33600000
  435. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  436. Description of the procurement:
    
    Drotaverini hydrochloridum No-Spa forte, 0,08 g, tabl., 20 tabl. ILOŚĆ 550
    
    Drotaverini hydrochloridum No-Spa, 0,04 g, tabl., 20 tabl. ILOŚĆ 350
    
    Drotaverini hydrochloridum No-Spa, 0,04 g/2ml, inj., 5 amp. ILOŚĆ 600.
  437. Award criteria:
  438. Information about options:
    Options: no
  439. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  440. Additional information:
  441. Title:
    
    Pakiet 56
  442. Additional CPV code(s):
    33600000
  443. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  444. Description of the procurement:
    
    Enalaprili maleas Benalapril 5 mg, tabl., 30 tabl. ILOŚĆ 80
    
    Enalaprili maleas Benalapril 10 mg, tabl., 30 tabl. ILOŚĆ 80
    
    Enalaprili maleas Benalapril 20 mg, tabl., 30 tabl. ILOŚĆ 40.
  445. Award criteria:
  446. Information about options:
    Options: no
  447. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  448. Additional information:
  449. Title:
    
    Pakiet 57
  450. Additional CPV code(s):
    33600000
  451. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  452. Description of the procurement:
    
    Epoetinum beta NeoRecormon 50000 wielodaw., 50 000 j.m., inj., 1 zest. ILOŚĆ 25
    
    Epoetinum beta NeoRecormon, 500j.m./0,3ml, roztw. do wstrzyk., 6 amp.strzy. ILOŚĆ 12.
  453. Award criteria:
  454. Information about options:
    Options: no
  455. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  456. Additional information:
  457. Title:
    
    Pakiet 58
  458. Additional CPV code(s):
    33600000
  459. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  460. Description of the procurement:
    
    Erytromycin Erythromycinum, 0,2 g, tabl.powl., 16 tabl. ILOŚĆ 80
    
    Erytromycin Erytromycinum inj.i.v.0,3 mg a 1 fiol. ILOŚĆ 180.
  461. Award criteria:
  462. Information about options:
    Options: no
  463. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  464. Additional information:
  465. Title:
    
    Pakiet 59
  466. Additional CPV code(s):
    33600000
  467. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  468. Description of the procurement:
    
    Escherichia coli Posterisan, 10 czop. ILOŚĆ 40
    
    Escherichia coli Posterisan, 25g maść ILOŚĆ 10.
  469. Award criteria:
  470. Information about options:
    Options: no
  471. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  472. Additional information:
  473. Title:
    
    Pakiet 60
  474. Additional CPV code(s):
    33600000
  475. Place of performance:
    Main site or place of performance:
    Apteka Szpitalna.
  476. Description of the procurement:
    
    Etamsylatum Cyclonamine, 0,25 g, tabl., 30 tabl. ILOŚĆ 300
    
    Etamsylatum Cyclonamine, 0,25 g/2ml, inj., 50 amp. ILOŚĆ 220.
  477. Award criteria:
  478. Information about options:
    Options: no
  479. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  480. Additional information:
  481. Title:
    
    Pakiet 61
  482. Additional CPV code(s):
    33600000
  483. Place of performanc

Pharmaceutical products (№2814046)

Link to original

Publication date

Description